Clinical Trials on Stage III Breast Cancer in France

Total 1591 results

NRG Oncology
National Cancer Institute (NCI)

Recruiting

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Stage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8

United States
Centre Hospitalier Régional Metz-Thionville
Central Hospital, Nancy, France; University of Lorraine

Completed

EMDR Psychotherapy for Anxious-depressive Symptoms in Breast Cancer Patient (PSYCANCER)

Breast Cancer Female

France
Groupe Hospitalier Mutualiste de Grenoble
TIMC-IMAG; AG2R La Mondiale; GEFLUC; Espoir Isère Cancer

Completed

Autohypnosis and Cancerology

Breast Cancer | Colorectal Cancer

France
Centre Oscar Lambret
Sysmex America, Inc.

Unknown

IDENTIFICATION OF SENTINEL NODE(S) IN BREAST CANCER (SENTIMAG)

BREAST CANCER

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

A Trial Evaluating the Safety & Efficacy of Intra-Tumoral Ipilimumab in Combination With Intra-venous Nivolumab in Patients With Metastatic Melanoma (NIVIPIT)

Stage III/IV Melanoma

France
Hospices Civils de Lyon

Recruiting

Immediate Breast Reconstruction's Increasing (IBRI)

Breast Cancer | Breast Reconstruction

France
Centre Antoine Lacassagne

Completed

Preoperative Localization of Infraclinical Breast Tumors: Isotopic Localization by iodine125 Seed Versus Standard Localization Using a Metal Wire (IodineBreast)

Breast Cancer

France
Ramsay Générale de Santé
European Clinical Trial Experts Network

Recruiting

Comparison of Changes in the Quality of Life of Patients Operated on Breast Cancer at the Drôme Ardèche Breast Institute According to Access to Supportive Oncological Care (IDSein) (IDSein)

Breast Cancer Female

France
Assistance Publique - Hôpitaux de Paris
Institut Pasteur

Completed

Prolactin Receptor and Breast Diseases (Prolacsein)

Breast Cancer | Benign Breast Disease

France
Institut du Cancer de Montpellier - Val d'Aurelle

Active, not recruiting

LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy (LEANOX)

Stage III Colon Cancer

France
Centre Francois Baclesse
Groupement Interrégional de Recherche Clinique et d'Innovation; NATSUCA laboratory

Recruiting

Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast Cancer (QISEIN)

Breast Cancer | Fatigue

France
Institut Claudius Regaud
Ligue contre le cancer, France

Recruiting

Male breAsT cAncer preDisposition Factor (MATADOR)

Breast Cancer

France
Institut Paoli-Calmettes
Laboratoire Management Sport Cancer EA 4670

Unknown

Feasibility Study of an Adapted and Supported Water Polo Program to Reduce Fatigue Related to Cancer and Improve Psychological and Social Recovery in Patients With Breast Cancer Remission (AQUA-POLO)

Breast Cancer | Cancer Related Fatigue

France
Institut Cancerologie de l'Ouest
SIRIC ILIAD

Completed

[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers (EITHICS)

Triple Negative Breast Cancer

France
Centre Leon Berard

Completed

Study of Impact of Routine "Clinical Cancer Department/Supportive Care Department" Consultation on the Prescription of an Additional Line of Chemotherapy

Metastatic Breast Cancer

France
Institut Bergonié

Completed

Assessment of Cognitive Function After Surgery in Two Types of Anesthesia in Patients Operated for Breast Cancer (HYPNOSEIN)

Patients With Breast Cancer and Breast Surgery Requiring

France
Jules Bordet Institute

Withdrawn

Biomarker Research Study for PF-03084014 in cHEmoresistant Triple-negative Breast cAncer (RHEA)

Breast Cancer

Belgium, France
Institut Claudius Regaud

Terminated

The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane. (REVER)

HER2-positive Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Sexual Quality of Life in Women During the First Year of Adjuvant Hormonal Treatment for Breast Cancer. (CUPIDON)

Quality of Life | Cancer | Breast Cancer

France
Centre Francois Baclesse

Terminated

Comparison of Diagnostic Performance of an Algorithm and a High Definition Classical Iterative Algorithm Positron Emission Tomography (PET) to 18Fluoro-deoxy-glucose (18FDG) in the Evaluation of Axillary Lymph Node Invasion of Breast Tumors (TEP-Sein)

Breast Cancer

France
University of California, Irvine

Recruiting

Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer

Breast Cancer | Metastatic Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor-positive Breast Cancer

United States
Novartis Pharmaceuticals

Terminated

Phase Ib/II Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer

Metastatic Breast Cancer (MBC) | Inoperable Locally Advanced Breast Cancer

France, Spain
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Evaluation of Sexual Quality of Life for Breast Cancer (CUPIDON2)

Quality of Life | Cancer | Breast Cancer

France
Institut Curie
Rain Oncology Inc

Terminated

Milademetan and Fulvestrant in GATA3-mutant, ER+HER- Advanced or Metastatic Breast Cancer (DEMETER)

Advanced or Metastatic Breast Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Trial of Ipilimumab After Isolated Limb Perfusion, in Patients With Metastases Melanoma (ILP+/-IPI)

In-transit Metastases Melanoma Stage IIIB and IIIC

France
National Cancer Institute (NCI)

Recruiting

Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Pathologic Stage III HPV-Mediated (p16-Positive)...

United States
Institut Cancerologie de l'Ouest
Fondation ARC; University of Angers, GRANEM

Unknown

Safety and Compliance of Renal Cancer Patients Treated by Non-IV Drugs (TOPTACOS)

Stage III Renal Cell Cancer | Metastatic Renal Cancer

France
Institut de Cancérologie de Lorraine

Not yet recruiting

Personalized Preventive Support for Cognitive Impairment in Non-Metastatic Breast Cancer (EFACog) (EFACog)

No Metastatic Breast Cancer

France
Institut Curie

Terminated

Changes in Phenotype and Genotype of Breast Cancers During the Metastatic Process and Optimization of Therapeutic Targeting (ESOPE)

Metastatic Breast Cancer

France
Institut Bergonié
Ligue contre le cancer, France

Unknown

High Intensity Focused Ultrasound Treatment of Breast Tumors. BRIFU Study (BRIFU)

Breast Cancer Female

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Development of Clinical and Biological Database (BCBInstitut)

Sarcoma | Breast Cancer | Gynecologic Cancer | Digestive Cancer

France
Institut Cancerologie de l'Ouest

Active, not recruiting

Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer (TEP-FES)

Metastatic Breast Cancer

France
UNICANCER

Completed

Study on Androgen Receptor and Triple Negative Breast Cancer (START)

Breast Cancer Female | Triple Negative and Androgen Receptor Positive

France
Hospices Civils de Lyon

Recruiting

Realistic Evaluation of a Job Retention Program After Breast Cancer (RECOVA-FTRACS)

Breast Cancer

France
Institut de cancérologie Strasbourg Europe
UR 3072

Recruiting

Characterization and Kinetic of Chemotherapy-induced Cardiovascular Toxicity in Breast Cancer (PROTECT-COEUR)

Breast Cancer

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Breast Cancer Prevention and Screening Membership (AdDePi_KS)

Breast Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris
Hoffmann-La Roche

Recruiting

Impact of Neoadjuvant Immunotherapy in Early Stage Breast Cancer Before Standard Therapy (BIS-Program)

Breast Cancer

France
Centre Hospitalier Universitaire de Besancon

Recruiting

Supervised Exercise, Sleep in Patients With Non Metastatic Breast Cancer (FATSOMCAN)

Breast Cancer

France
University Hospital, Strasbourg, France

Completed

Clinical Validation of an Artificial Intelligence Algorithm to Help Interpret Mammograms (ALGO-MAMMO)

Breast Cancer

France
Centre Georges Francois Leclerc

Completed

Osteopathy and Prevention of Gastrointestinal Side Effects in Women Treated for Breast Cancer (PREDIGOSTEO)

Breast Cancer

France
Institut Cancerologie de l'Ouest

Active, not recruiting

Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer (PRESAGE)

Breast Cancer

France
Institut de cancérologie Strasbourg Europe
UR 3072 - Mitochondries, Stress oxydant, Protection musculaire

Completed

Impact of (Neo)Adjuvant Therapy Associating Anthracyclines and Taxanes With or Without Trastuzumab on Skeletal Muscle in Breast Cancer Patients (PROTECT-03)

Breast Cancer

France
Institut Claudius Regaud

Completed

Circulating Cancer Cells/Macrophage HYbrid Cells in Patients With Breast Cancer. (CARMMYC)

Breast Cancer

France
Centre Francois Baclesse
National Cancer Institute, France; Ligue contre le cancer, France

Completed

Management of Cognitive Difficulties After Cancer Treatments in Women Treated for Breast Cancer: Feasibility Study (Step 1 of the Cog-Stim Protocol) (COG STIM)

Breast Cancer

France
University Hospital, Toulouse

Completed

Impact of Adjuvant Hormone Therapy on Bone and Cardiovascular Risk (IMPACTTHKS)

Breast Cancer

France
Assistance Publique - Hôpitaux de Paris

Completed

Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility (DECISIF)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Hypnosis for Patients Treated With Adjuvant Chemotherapy for Breast Cancer(HYPNOVAL) (HYPNOVAL)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle
Cemka-Eval

Terminated

Implementation and Evaluation of a Social Journey Accompanied in Breast Cancer Diagnosis (EPARS SEIN) (EPARS-SEIN)

Breast Cancer

France
Assistance Publique - Hôpitaux de Paris

Unknown

BIOPSY SCANNER LLTECH© Technology for Diagnosis of Breast Cancer (LLTECHBreast)

Breast Cancer

France
University Hospital, Bordeaux
SRIOP 2016, SIRIC BRIO

Completed

Adaptation of a Knowledges Exchange Portal Between (KEP) Healers and Patients : Obstacles and Sources to KEP Use for Breast Cancer Women (Sav-AQ)

Breast Cancer

France

3

Subscribe